nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ABCC1—Zoledronate—Paget's disease of bone	0.229	1	CbGbCtD
Vandetanib—Gastroenteritis—Risedronate—Paget's disease of bone	0.00225	0.00512	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.00222	0.00507	CcSEcCtD
Vandetanib—Gastritis—Alendronate—Paget's disease of bone	0.0022	0.005	CcSEcCtD
Vandetanib—Neoplasm—Zoledronate—Paget's disease of bone	0.00215	0.0049	CcSEcCtD
Vandetanib—Dysphagia—Alendronate—Paget's disease of bone	0.00214	0.00489	CcSEcCtD
Vandetanib—Asthenia—Tiludronate—Paget's disease of bone	0.00214	0.00488	CcSEcCtD
Vandetanib—Diarrhoea—Tiludronate—Paget's disease of bone	0.00204	0.00466	CcSEcCtD
Vandetanib—Atrial fibrillation—Pamidronate—Paget's disease of bone	0.002	0.00455	CcSEcCtD
Vandetanib—Dizziness—Tiludronate—Paget's disease of bone	0.00198	0.0045	CcSEcCtD
Vandetanib—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00196	0.00446	CcSEcCtD
Vandetanib—Cardiac failure—Pamidronate—Paget's disease of bone	0.00194	0.00442	CcSEcCtD
Vandetanib—Lethargy—Pamidronate—Paget's disease of bone	0.00193	0.0044	CcSEcCtD
Vandetanib—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.0019	0.00434	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.0019	0.00432	CcSEcCtD
Vandetanib—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.00189	0.00431	CcSEcCtD
Vandetanib—Headache—Tiludronate—Paget's disease of bone	0.00187	0.00426	CcSEcCtD
Vandetanib—Stomatitis—Alendronate—Paget's disease of bone	0.00186	0.00425	CcSEcCtD
Vandetanib—Atrial fibrillation—Zoledronate—Paget's disease of bone	0.00182	0.00416	CcSEcCtD
Vandetanib—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00178	0.00406	CcSEcCtD
Vandetanib—Alopecia—Etidronic acid—Paget's disease of bone	0.00178	0.00406	CcSEcCtD
Vandetanib—Nausea—Tiludronate—Paget's disease of bone	0.00177	0.00404	CcSEcCtD
Vandetanib—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.00177	0.00404	CcSEcCtD
Vandetanib—Lethargy—Zoledronate—Paget's disease of bone	0.00176	0.00402	CcSEcCtD
Vandetanib—Gastritis—Risedronate—Paget's disease of bone	0.00176	0.00401	CcSEcCtD
Vandetanib—Haemoglobin—Alendronate—Paget's disease of bone	0.00172	0.00393	CcSEcCtD
Vandetanib—Hypokalaemia—Pamidronate—Paget's disease of bone	0.00172	0.00392	CcSEcCtD
Vandetanib—Influenza—Risedronate—Paget's disease of bone	0.00172	0.00392	CcSEcCtD
Vandetanib—Haemorrhage—Alendronate—Paget's disease of bone	0.00172	0.00391	CcSEcCtD
Vandetanib—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.00169	0.00386	CcSEcCtD
Vandetanib—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00169	0.00384	CcSEcCtD
Vandetanib—Gastritis—Pamidronate—Paget's disease of bone	0.00167	0.00382	CcSEcCtD
Vandetanib—Bronchitis—Risedronate—Paget's disease of bone	0.00165	0.00377	CcSEcCtD
Vandetanib—Influenza—Pamidronate—Paget's disease of bone	0.00164	0.00373	CcSEcCtD
Vandetanib—Erythema multiforme—Alendronate—Paget's disease of bone	0.00162	0.0037	CcSEcCtD
Vandetanib—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.00162	0.00369	CcSEcCtD
Vandetanib—Bronchospasm—Pamidronate—Paget's disease of bone	0.00161	0.00367	CcSEcCtD
Vandetanib—Dehydration—Zoledronate—Paget's disease of bone	0.00161	0.00366	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.0016	0.00364	CcSEcCtD
Vandetanib—Hypokalaemia—Zoledronate—Paget's disease of bone	0.00157	0.00358	CcSEcCtD
Vandetanib—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.00155	0.00352	CcSEcCtD
Vandetanib—Pneumonia—Risedronate—Paget's disease of bone	0.00154	0.00352	CcSEcCtD
Vandetanib—Infestation—Risedronate—Paget's disease of bone	0.00153	0.00349	CcSEcCtD
Vandetanib—Infestation NOS—Risedronate—Paget's disease of bone	0.00153	0.00349	CcSEcCtD
Vandetanib—Gastritis—Zoledronate—Paget's disease of bone	0.00153	0.00349	CcSEcCtD
Vandetanib—Depression—Risedronate—Paget's disease of bone	0.00153	0.00348	CcSEcCtD
Vandetanib—Neutropenia—Pamidronate—Paget's disease of bone	0.00153	0.00348	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00152	0.00346	CcSEcCtD
Vandetanib—Alopecia—Alendronate—Paget's disease of bone	0.00152	0.00346	CcSEcCtD
Vandetanib—Influenza—Zoledronate—Paget's disease of bone	0.00149	0.0034	CcSEcCtD
Vandetanib—Dysphagia—Zoledronate—Paget's disease of bone	0.00149	0.0034	CcSEcCtD
Vandetanib—Arthralgia—Etidronic acid—Paget's disease of bone	0.00149	0.0034	CcSEcCtD
Vandetanib—Urinary tract infection—Risedronate—Paget's disease of bone	0.00149	0.0034	CcSEcCtD
Vandetanib—Conjunctivitis—Risedronate—Paget's disease of bone	0.00149	0.0034	CcSEcCtD
Vandetanib—Bronchospasm—Zoledronate—Paget's disease of bone	0.00147	0.00335	CcSEcCtD
Vandetanib—Pneumonia—Pamidronate—Paget's disease of bone	0.00147	0.00334	CcSEcCtD
Vandetanib—Dysgeusia—Alendronate—Paget's disease of bone	0.00146	0.00333	CcSEcCtD
Vandetanib—Infestation NOS—Pamidronate—Paget's disease of bone	0.00146	0.00332	CcSEcCtD
Vandetanib—Infestation—Pamidronate—Paget's disease of bone	0.00146	0.00332	CcSEcCtD
Vandetanib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00145	0.00331	CcSEcCtD
Vandetanib—Sinusitis—Risedronate—Paget's disease of bone	0.00144	0.00328	CcSEcCtD
Vandetanib—Muscle spasms—Alendronate—Paget's disease of bone	0.00144	0.00327	CcSEcCtD
Vandetanib—Renal failure—Pamidronate—Paget's disease of bone	0.00143	0.00327	CcSEcCtD
Vandetanib—Infection—Etidronic acid—Paget's disease of bone	0.00142	0.00324	CcSEcCtD
Vandetanib—Stomatitis—Pamidronate—Paget's disease of bone	0.00142	0.00324	CcSEcCtD
Vandetanib—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00142	0.00323	CcSEcCtD
Vandetanib—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00142	0.00323	CcSEcCtD
Vandetanib—Neutropenia—Zoledronate—Paget's disease of bone	0.0014	0.00318	CcSEcCtD
Vandetanib—Haematuria—Pamidronate—Paget's disease of bone	0.00139	0.00317	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00139	0.00316	CcSEcCtD
Vandetanib—Haemoglobin—Risedronate—Paget's disease of bone	0.00138	0.00315	CcSEcCtD
Vandetanib—Pollakiuria—Zoledronate—Paget's disease of bone	0.00138	0.00314	CcSEcCtD
Vandetanib—Haemorrhage—Risedronate—Paget's disease of bone	0.00138	0.00314	CcSEcCtD
Vandetanib—Sinusitis—Pamidronate—Paget's disease of bone	0.00137	0.00312	CcSEcCtD
Vandetanib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00136	0.0031	CcSEcCtD
Vandetanib—Weight decreased—Zoledronate—Paget's disease of bone	0.00135	0.00308	CcSEcCtD
Vandetanib—Urethral disorder—Risedronate—Paget's disease of bone	0.00135	0.00308	CcSEcCtD
Vandetanib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00133	0.00303	CcSEcCtD
Vandetanib—Infestation—Zoledronate—Paget's disease of bone	0.00133	0.00303	CcSEcCtD
Vandetanib—Depression—Zoledronate—Paget's disease of bone	0.00133	0.00303	CcSEcCtD
Vandetanib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00132	0.003	CcSEcCtD
Vandetanib—Renal failure—Zoledronate—Paget's disease of bone	0.00131	0.00298	CcSEcCtD
Vandetanib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00131	0.00298	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.0013	0.00297	CcSEcCtD
Vandetanib—Stomatitis—Zoledronate—Paget's disease of bone	0.0013	0.00296	CcSEcCtD
Vandetanib—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00129	0.00295	CcSEcCtD
Vandetanib—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00129	0.00295	CcSEcCtD
Vandetanib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00129	0.00295	CcSEcCtD
Vandetanib—Eye disorder—Risedronate—Paget's disease of bone	0.00129	0.00293	CcSEcCtD
Vandetanib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00128	0.00293	CcSEcCtD
Vandetanib—Urethral disorder—Pamidronate—Paget's disease of bone	0.00128	0.00292	CcSEcCtD
Vandetanib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00128	0.00291	CcSEcCtD
Vandetanib—Chest pain—Alendronate—Paget's disease of bone	0.00127	0.0029	CcSEcCtD
Vandetanib—Haematuria—Zoledronate—Paget's disease of bone	0.00127	0.00289	CcSEcCtD
Vandetanib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00126	0.00287	CcSEcCtD
Vandetanib—Angiopathy—Risedronate—Paget's disease of bone	0.00125	0.00285	CcSEcCtD
Vandetanib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00124	0.00283	CcSEcCtD
Vandetanib—Arrhythmia—Risedronate—Paget's disease of bone	0.00123	0.0028	CcSEcCtD
Vandetanib—Constipation—Etidronic acid—Paget's disease of bone	0.00122	0.00279	CcSEcCtD
Vandetanib—Eye disorder—Pamidronate—Paget's disease of bone	0.00122	0.00279	CcSEcCtD
Vandetanib—Bradycardia—Zoledronate—Paget's disease of bone	0.00122	0.00277	CcSEcCtD
Vandetanib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00121	0.00277	CcSEcCtD
Vandetanib—Infection—Alendronate—Paget's disease of bone	0.00121	0.00276	CcSEcCtD
Vandetanib—Mental disorder—Risedronate—Paget's disease of bone	0.00121	0.00275	CcSEcCtD
Vandetanib—Malnutrition—Risedronate—Paget's disease of bone	0.0012	0.00273	CcSEcCtD
Vandetanib—Angiopathy—Pamidronate—Paget's disease of bone	0.00119	0.00271	CcSEcCtD
Vandetanib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00118	0.00269	CcSEcCtD
Vandetanib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00118	0.00269	CcSEcCtD
Vandetanib—Urethral disorder—Zoledronate—Paget's disease of bone	0.00117	0.00267	CcSEcCtD
Vandetanib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00117	0.00267	CcSEcCtD
Vandetanib—Alopecia—Pamidronate—Paget's disease of bone	0.00116	0.00264	CcSEcCtD
Vandetanib—Muscle spasms—Risedronate—Paget's disease of bone	0.00115	0.00263	CcSEcCtD
Vandetanib—ABL1—p73 transcription factor network—PML—Paget's disease of bone	0.00115	0.00347	CbGpPWpGaD
Vandetanib—SRC—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00115	0.00345	CbGpPWpGaD
Vandetanib—Malnutrition—Pamidronate—Paget's disease of bone	0.00114	0.0026	CcSEcCtD
Vandetanib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00113	0.00258	CcSEcCtD
Vandetanib—Eye disorder—Zoledronate—Paget's disease of bone	0.00112	0.00255	CcSEcCtD
Vandetanib—Dysgeusia—Pamidronate—Paget's disease of bone	0.00112	0.00254	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00111	0.00253	CcSEcCtD
Vandetanib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00111	0.00253	CcSEcCtD
Vandetanib—Muscle spasms—Pamidronate—Paget's disease of bone	0.0011	0.0025	CcSEcCtD
Vandetanib—Angiopathy—Zoledronate—Paget's disease of bone	0.00108	0.00247	CcSEcCtD
Vandetanib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00108	0.00246	CcSEcCtD
Vandetanib—Dyspepsia—Alendronate—Paget's disease of bone	0.00107	0.00245	CcSEcCtD
Vandetanib—Arrhythmia—Zoledronate—Paget's disease of bone	0.00107	0.00243	CcSEcCtD
Vandetanib—LYN—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00106	0.0032	CbGpPWpGaD
Vandetanib—LCK—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.00106	0.00318	CbGpPWpGaD
Vandetanib—Alopecia—Zoledronate—Paget's disease of bone	0.00106	0.00241	CcSEcCtD
Vandetanib—SRC—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00105	0.00317	CbGpPWpGaD
Vandetanib—Loss of consciousness—Risedronate—Paget's disease of bone	0.00105	0.0024	CcSEcCtD
Vandetanib—Mental disorder—Zoledronate—Paget's disease of bone	0.00105	0.00239	CcSEcCtD
Vandetanib—FYN—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00105	0.00315	CbGpPWpGaD
Vandetanib—Cough—Risedronate—Paget's disease of bone	0.00105	0.00238	CcSEcCtD
Vandetanib—YES1—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00105	0.00315	CbGpPWpGaD
Vandetanib—Pain—Alendronate—Paget's disease of bone	0.00104	0.00238	CcSEcCtD
Vandetanib—Constipation—Alendronate—Paget's disease of bone	0.00104	0.00238	CcSEcCtD
Vandetanib—Malnutrition—Zoledronate—Paget's disease of bone	0.00104	0.00237	CcSEcCtD
Vandetanib—PLK4—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00104	0.00313	CbGpPWpGaD
Vandetanib—Hypertension—Risedronate—Paget's disease of bone	0.00103	0.00236	CcSEcCtD
Vandetanib—SRC—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00102	0.00308	CbGpPWpGaD
Vandetanib—Chest pain—Risedronate—Paget's disease of bone	0.00102	0.00233	CcSEcCtD
Vandetanib—Arthralgia—Risedronate—Paget's disease of bone	0.00102	0.00233	CcSEcCtD
Vandetanib—Dysgeusia—Zoledronate—Paget's disease of bone	0.00102	0.00232	CcSEcCtD
Vandetanib—Anxiety—Risedronate—Paget's disease of bone	0.00102	0.00232	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00101	0.00231	CcSEcCtD
Vandetanib—Pruritus—Etidronic acid—Paget's disease of bone	0.00101	0.00231	CcSEcCtD
Vandetanib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.001	0.00228	CcSEcCtD
Vandetanib—Muscle spasms—Zoledronate—Paget's disease of bone	0.001	0.00228	CcSEcCtD
Vandetanib—Dry mouth—Risedronate—Paget's disease of bone	0.000998	0.00227	CcSEcCtD
Vandetanib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000997	0.00227	CcSEcCtD
Vandetanib—MAP2K5—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000997	0.003	CbGpPWpGaD
Vandetanib—Cough—Pamidronate—Paget's disease of bone	0.000994	0.00227	CcSEcCtD
Vandetanib—Convulsion—Pamidronate—Paget's disease of bone	0.000987	0.00225	CcSEcCtD
Vandetanib—Hypertension—Pamidronate—Paget's disease of bone	0.000984	0.00224	CcSEcCtD
Vandetanib—MAP2K5—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000982	0.00295	CbGpPWpGaD
Vandetanib—Vision blurred—Zoledronate—Paget's disease of bone	0.000981	0.00224	CcSEcCtD
Vandetanib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000979	0.00223	CcSEcCtD
Vandetanib—Tremor—Zoledronate—Paget's disease of bone	0.000975	0.00222	CcSEcCtD
Vandetanib—Infection—Risedronate—Paget's disease of bone	0.000972	0.00221	CcSEcCtD
Vandetanib—SRC—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.000971	0.00292	CbGpPWpGaD
Vandetanib—Arthralgia—Pamidronate—Paget's disease of bone	0.00097	0.00221	CcSEcCtD
Vandetanib—Anxiety—Pamidronate—Paget's disease of bone	0.000967	0.0022	CcSEcCtD
Vandetanib—Body temperature increased—Alendronate—Paget's disease of bone	0.000964	0.0022	CcSEcCtD
Vandetanib—Abdominal pain—Alendronate—Paget's disease of bone	0.000964	0.0022	CcSEcCtD
Vandetanib—Nervous system disorder—Risedronate—Paget's disease of bone	0.000959	0.00219	CcSEcCtD
Vandetanib—VEGFA—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000957	0.00288	CbGpPWpGaD
Vandetanib—Skin disorder—Risedronate—Paget's disease of bone	0.00095	0.00217	CcSEcCtD
Vandetanib—LYN—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000948	0.00285	CbGpPWpGaD
Vandetanib—FYN—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000933	0.00281	CbGpPWpGaD
Vandetanib—LYN—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000932	0.00281	CbGpPWpGaD
Vandetanib—Oedema—Pamidronate—Paget's disease of bone	0.00093	0.00212	CcSEcCtD
Vandetanib—PLK4—Cell Cycle—OPTN—Paget's disease of bone	0.000929	0.00279	CbGpPWpGaD
Vandetanib—Infection—Pamidronate—Paget's disease of bone	0.000924	0.00211	CcSEcCtD
Vandetanib—FYN—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000918	0.00276	CbGpPWpGaD
Vandetanib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000915	0.00208	CcSEcCtD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000912	0.00275	CbGpPWpGaD
Vandetanib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.000912	0.00208	CcSEcCtD
Vandetanib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000911	0.00207	CcSEcCtD
Vandetanib—Vomiting—Etidronic acid—Paget's disease of bone	0.00091	0.00207	CcSEcCtD
Vandetanib—Cough—Zoledronate—Paget's disease of bone	0.000908	0.00207	CcSEcCtD
Vandetanib—VEGFA—Cellular responses to stress—VCP—Paget's disease of bone	0.000906	0.00273	CbGpPWpGaD
Vandetanib—Rash—Etidronic acid—Paget's disease of bone	0.000902	0.00206	CcSEcCtD
Vandetanib—Convulsion—Zoledronate—Paget's disease of bone	0.000902	0.00205	CcSEcCtD
Vandetanib—Dermatitis—Etidronic acid—Paget's disease of bone	0.000901	0.00205	CcSEcCtD
Vandetanib—Hypertension—Zoledronate—Paget's disease of bone	0.000899	0.00205	CcSEcCtD
Vandetanib—Headache—Etidronic acid—Paget's disease of bone	0.000896	0.00204	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000891	0.00203	CcSEcCtD
Vandetanib—FYN—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.000888	0.00267	CbGpPWpGaD
Vandetanib—Arthralgia—Zoledronate—Paget's disease of bone	0.000886	0.00202	CcSEcCtD
Vandetanib—Chest pain—Zoledronate—Paget's disease of bone	0.000886	0.00202	CcSEcCtD
Vandetanib—Insomnia—Risedronate—Paget's disease of bone	0.000885	0.00202	CcSEcCtD
Vandetanib—Anxiety—Zoledronate—Paget's disease of bone	0.000883	0.00201	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00088	0.00201	CcSEcCtD
Vandetanib—Paraesthesia—Risedronate—Paget's disease of bone	0.000878	0.002	CcSEcCtD
Vandetanib—Asthenia—Alendronate—Paget's disease of bone	0.000875	0.00199	CcSEcCtD
Vandetanib—Dyspnoea—Risedronate—Paget's disease of bone	0.000872	0.00199	CcSEcCtD
Vandetanib—LCK—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.000872	0.00262	CbGpPWpGaD
Vandetanib—LYN—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00087	0.00262	CbGpPWpGaD
Vandetanib—Dry mouth—Zoledronate—Paget's disease of bone	0.000867	0.00197	CcSEcCtD
Vandetanib—Pruritus—Alendronate—Paget's disease of bone	0.000863	0.00197	CcSEcCtD
Vandetanib—Dyspepsia—Risedronate—Paget's disease of bone	0.000861	0.00196	CcSEcCtD
Vandetanib—FYN—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000856	0.00258	CbGpPWpGaD
Vandetanib—Nausea—Etidronic acid—Paget's disease of bone	0.00085	0.00194	CcSEcCtD
Vandetanib—Oedema—Zoledronate—Paget's disease of bone	0.000849	0.00194	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000847	0.00193	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000845	0.00192	CcSEcCtD
Vandetanib—Infection—Zoledronate—Paget's disease of bone	0.000844	0.00192	CcSEcCtD
Vandetanib—Fatigue—Risedronate—Paget's disease of bone	0.000843	0.00192	CcSEcCtD
Vandetanib—Insomnia—Pamidronate—Paget's disease of bone	0.000841	0.00192	CcSEcCtD
Vandetanib—Pain—Risedronate—Paget's disease of bone	0.000837	0.00191	CcSEcCtD
Vandetanib—Constipation—Risedronate—Paget's disease of bone	0.000837	0.00191	CcSEcCtD
Vandetanib—Paraesthesia—Pamidronate—Paget's disease of bone	0.000835	0.0019	CcSEcCtD
Vandetanib—Diarrhoea—Alendronate—Paget's disease of bone	0.000834	0.0019	CcSEcCtD
Vandetanib—ALB—Folate Metabolism—CSF1—Paget's disease of bone	0.000834	0.00251	CbGpPWpGaD
Vandetanib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000833	0.0019	CcSEcCtD
Vandetanib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000832	0.0019	CcSEcCtD
Vandetanib—Dyspnoea—Pamidronate—Paget's disease of bone	0.000829	0.00189	CcSEcCtD
Vandetanib—Skin disorder—Zoledronate—Paget's disease of bone	0.000825	0.00188	CcSEcCtD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000825	0.00248	CbGpPWpGaD
Vandetanib—Dyspepsia—Pamidronate—Paget's disease of bone	0.000819	0.00187	CcSEcCtD
Vandetanib—FYN—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.000818	0.00246	CbGpPWpGaD
Vandetanib—Decreased appetite—Pamidronate—Paget's disease of bone	0.000808	0.00184	CcSEcCtD
Vandetanib—Dizziness—Alendronate—Paget's disease of bone	0.000806	0.00184	CcSEcCtD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000806	0.00243	CbGpPWpGaD
Vandetanib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000803	0.00183	CcSEcCtD
Vandetanib—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.000802	0.00241	CbGpPWpGaD
Vandetanib—Fatigue—Pamidronate—Paget's disease of bone	0.000802	0.00183	CcSEcCtD
Vandetanib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.0008	0.00182	CcSEcCtD
Vandetanib—Constipation—Pamidronate—Paget's disease of bone	0.000795	0.00181	CcSEcCtD
Vandetanib—Pain—Pamidronate—Paget's disease of bone	0.000795	0.00181	CcSEcCtD
Vandetanib—VEGFA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000793	0.00239	CbGpPWpGaD
Vandetanib—LYN—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00078	0.00235	CbGpPWpGaD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000778	0.00234	CbGpPWpGaD
Vandetanib—LCK—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000777	0.00234	CbGpPWpGaD
Vandetanib—Vomiting—Alendronate—Paget's disease of bone	0.000775	0.00177	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000774	0.00176	CcSEcCtD
Vandetanib—Body temperature increased—Risedronate—Paget's disease of bone	0.000773	0.00176	CcSEcCtD
Vandetanib—Abdominal pain—Risedronate—Paget's disease of bone	0.000773	0.00176	CcSEcCtD
Vandetanib—SRC—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.000772	0.00232	CbGpPWpGaD
Vandetanib—Rash—Alendronate—Paget's disease of bone	0.000769	0.00175	CcSEcCtD
Vandetanib—Insomnia—Zoledronate—Paget's disease of bone	0.000768	0.00175	CcSEcCtD
Vandetanib—Dermatitis—Alendronate—Paget's disease of bone	0.000768	0.00175	CcSEcCtD
Vandetanib—FYN—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000768	0.00231	CbGpPWpGaD
Vandetanib—FYN—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000766	0.00231	CbGpPWpGaD
Vandetanib—LCK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000764	0.0023	CbGpPWpGaD
Vandetanib—Headache—Alendronate—Paget's disease of bone	0.000764	0.00174	CcSEcCtD
Vandetanib—Paraesthesia—Zoledronate—Paget's disease of bone	0.000763	0.00174	CcSEcCtD
Vandetanib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00076	0.00173	CcSEcCtD
Vandetanib—Dyspnoea—Zoledronate—Paget's disease of bone	0.000757	0.00173	CcSEcCtD
Vandetanib—Dyspepsia—Zoledronate—Paget's disease of bone	0.000748	0.0017	CcSEcCtD
Vandetanib—LCK—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.000739	0.00222	CbGpPWpGaD
Vandetanib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000738	0.00168	CcSEcCtD
Vandetanib—PLK4—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000738	0.00222	CbGpPWpGaD
Vandetanib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000735	0.00168	CcSEcCtD
Vandetanib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000735	0.00168	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000733	0.00167	CcSEcCtD
Vandetanib—Fatigue—Zoledronate—Paget's disease of bone	0.000732	0.00167	CcSEcCtD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000729	0.00219	CbGpPWpGaD
Vandetanib—Pain—Zoledronate—Paget's disease of bone	0.000726	0.00166	CcSEcCtD
Vandetanib—Constipation—Zoledronate—Paget's disease of bone	0.000726	0.00166	CcSEcCtD
Vandetanib—Nausea—Alendronate—Paget's disease of bone	0.000724	0.00165	CcSEcCtD
Vandetanib—LCK—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000713	0.00215	CbGpPWpGaD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000703	0.00212	CbGpPWpGaD
Vandetanib—Asthenia—Risedronate—Paget's disease of bone	0.000702	0.0016	CcSEcCtD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000697	0.0021	CbGpPWpGaD
Vandetanib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000695	0.00158	CcSEcCtD
Vandetanib—Pruritus—Risedronate—Paget's disease of bone	0.000692	0.00158	CcSEcCtD
Vandetanib—ABL1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000686	0.00207	CbGpPWpGaD
Vandetanib—SRC—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000677	0.00204	CbGpPWpGaD
Vandetanib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000672	0.00153	CcSEcCtD
Vandetanib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000672	0.00153	CcSEcCtD
Vandetanib—Diarrhoea—Risedronate—Paget's disease of bone	0.000669	0.00153	CcSEcCtD
Vandetanib—Asthenia—Pamidronate—Paget's disease of bone	0.000667	0.00152	CcSEcCtD
Vandetanib—PLK4—Cell Cycle—NUP205—Paget's disease of bone	0.00066	0.00199	CbGpPWpGaD
Vandetanib—Pruritus—Pamidronate—Paget's disease of bone	0.000658	0.0015	CcSEcCtD
Vandetanib—TEK—Hemostasis—INPP5D—Paget's disease of bone	0.000652	0.00196	CbGpPWpGaD
Vandetanib—Dizziness—Risedronate—Paget's disease of bone	0.000647	0.00147	CcSEcCtD
Vandetanib—LCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000639	0.00192	CbGpPWpGaD
Vandetanib—YES1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000638	0.00192	CbGpPWpGaD
Vandetanib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000636	0.00145	CcSEcCtD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000631	0.0019	CbGpPWpGaD
Vandetanib—ABL1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000626	0.00188	CbGpPWpGaD
Vandetanib—EGFR—Direct p53 effectors—PML—Paget's disease of bone	0.000623	0.00187	CbGpPWpGaD
Vandetanib—Vomiting—Risedronate—Paget's disease of bone	0.000622	0.00142	CcSEcCtD
Vandetanib—RIPK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00062	0.00187	CbGpPWpGaD
Vandetanib—Rash—Risedronate—Paget's disease of bone	0.000617	0.00141	CcSEcCtD
Vandetanib—Dermatitis—Risedronate—Paget's disease of bone	0.000616	0.0014	CcSEcCtD
Vandetanib—Dizziness—Pamidronate—Paget's disease of bone	0.000615	0.0014	CcSEcCtD
Vandetanib—Headache—Risedronate—Paget's disease of bone	0.000613	0.0014	CcSEcCtD
Vandetanib—FYN—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.00061	0.00184	CbGpPWpGaD
Vandetanib—Asthenia—Zoledronate—Paget's disease of bone	0.000609	0.00139	CcSEcCtD
Vandetanib—Pruritus—Zoledronate—Paget's disease of bone	0.000601	0.00137	CcSEcCtD
Vandetanib—Vomiting—Pamidronate—Paget's disease of bone	0.000591	0.00135	CcSEcCtD
Vandetanib—EGFR—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000586	0.00176	CbGpPWpGaD
Vandetanib—Rash—Pamidronate—Paget's disease of bone	0.000586	0.00134	CcSEcCtD
Vandetanib—Dermatitis—Pamidronate—Paget's disease of bone	0.000586	0.00133	CcSEcCtD
Vandetanib—Headache—Pamidronate—Paget's disease of bone	0.000583	0.00133	CcSEcCtD
Vandetanib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000581	0.00132	CcSEcCtD
Vandetanib—Nausea—Risedronate—Paget's disease of bone	0.000581	0.00132	CcSEcCtD
Vandetanib—SRC—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.000579	0.00174	CbGpPWpGaD
Vandetanib—FYN—HIV Infection—NUP205—Paget's disease of bone	0.000577	0.00174	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000569	0.00171	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000567	0.00171	CbGpPWpGaD
Vandetanib—SRC—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000565	0.0017	CbGpPWpGaD
Vandetanib—YES1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000564	0.0017	CbGpPWpGaD
Vandetanib—Dizziness—Zoledronate—Paget's disease of bone	0.000562	0.00128	CcSEcCtD
Vandetanib—SRC—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000557	0.00168	CbGpPWpGaD
Vandetanib—Nausea—Pamidronate—Paget's disease of bone	0.000552	0.00126	CcSEcCtD
Vandetanib—ERBB3—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000547	0.00164	CbGpPWpGaD
Vandetanib—YES1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000544	0.00164	CbGpPWpGaD
Vandetanib—Vomiting—Zoledronate—Paget's disease of bone	0.00054	0.00123	CcSEcCtD
Vandetanib—Rash—Zoledronate—Paget's disease of bone	0.000536	0.00122	CcSEcCtD
Vandetanib—Dermatitis—Zoledronate—Paget's disease of bone	0.000535	0.00122	CcSEcCtD
Vandetanib—EGFR—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000535	0.00161	CbGpPWpGaD
Vandetanib—Headache—Zoledronate—Paget's disease of bone	0.000532	0.00121	CcSEcCtD
Vandetanib—Nausea—Zoledronate—Paget's disease of bone	0.000505	0.00115	CcSEcCtD
Vandetanib—AXL—Signaling Pathways—VCP—Paget's disease of bone	0.000489	0.00147	CbGpPWpGaD
Vandetanib—YES1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000488	0.00147	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000486	0.00146	CbGpPWpGaD
Vandetanib—MKNK1—Disease—VCP—Paget's disease of bone	0.000484	0.00146	CbGpPWpGaD
Vandetanib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.00048	0.00145	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000476	0.00143	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000469	0.00141	CbGpPWpGaD
Vandetanib—SRC—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000456	0.00137	CbGpPWpGaD
Vandetanib—SRC—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000449	0.00135	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—VCP—Paget's disease of bone	0.000447	0.00135	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000421	0.00127	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—INPP5D—Paget's disease of bone	0.00042	0.00126	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000415	0.00125	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000414	0.00125	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—VCP—Paget's disease of bone	0.000409	0.00123	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000406	0.00122	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.0004	0.0012	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00039	0.00117	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000379	0.00114	CbGpPWpGaD
Vandetanib—MKNK1—Disease—NUP205—Paget's disease of bone	0.00037	0.00111	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000365	0.0011	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000364	0.0011	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000364	0.0011	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000358	0.00108	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000352	0.00106	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—INPP5D—Paget's disease of bone	0.000351	0.00106	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000345	0.00104	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—VCP—Paget's disease of bone	0.000339	0.00102	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—INPP5D—Paget's disease of bone	0.000339	0.00102	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000334	0.001	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000333	0.001	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—NUP205—Paget's disease of bone	0.000327	0.000984	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000304	0.000916	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000298	0.000898	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—NUP205—Paget's disease of bone	0.000298	0.000897	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000293	0.000882	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000293	0.000882	CbGpPWpGaD
Vandetanib—ERBB3—Disease—VCP—Paget's disease of bone	0.000287	0.000864	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000286	0.00086	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—INPP5D—Paget's disease of bone	0.000279	0.000839	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—CALCA—Paget's disease of bone	0.000278	0.000835	CbGpPWpGaD
Vandetanib—MKNK1—Disease—CALCA—Paget's disease of bone	0.000275	0.000827	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—NUP205—Paget's disease of bone	0.000269	0.000811	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—PML—Paget's disease of bone	0.000263	0.000792	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000261	0.000787	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00026	0.000781	CbGpPWpGaD
Vandetanib—BLK—Immune System—NUP205—Paget's disease of bone	0.000259	0.00078	CbGpPWpGaD
Vandetanib—FGR—Immune System—NUP205—Paget's disease of bone	0.000258	0.000777	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—INPP5D—Paget's disease of bone	0.000254	0.000765	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000254	0.000764	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—INPP5D—Paget's disease of bone	0.000253	0.000761	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	0.000252	0.000757	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—INPP5D—Paget's disease of bone	0.000249	0.000749	CbGpPWpGaD
Vandetanib—ALB—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000247	0.000745	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000239	0.00072	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—PML—Paget's disease of bone	0.000238	0.000717	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—NUP205—Paget's disease of bone	0.000238	0.000715	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—NUP205—Paget's disease of bone	0.000234	0.000703	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—CALCA—Paget's disease of bone	0.000232	0.000699	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000232	0.000697	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—INPP5D—Paget's disease of bone	0.00023	0.000691	CbGpPWpGaD
Vandetanib—BLK—Immune System—PML—Paget's disease of bone	0.000229	0.000689	CbGpPWpGaD
Vandetanib—FGR—Immune System—PML—Paget's disease of bone	0.000228	0.000687	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—VCP—Paget's disease of bone	0.000228	0.000686	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—SQSTM1—Paget's disease of bone	0.000228	0.000685	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000223	0.000672	CbGpPWpGaD
Vandetanib—BLK—Immune System—INPP5D—Paget's disease of bone	0.000221	0.000665	CbGpPWpGaD
Vandetanib—FGR—Immune System—INPP5D—Paget's disease of bone	0.00022	0.000663	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NUP205—Paget's disease of bone	0.000219	0.00066	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000219	0.000658	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000215	0.000648	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PML—Paget's disease of bone	0.00021	0.000632	CbGpPWpGaD
Vandetanib—YES1—Immune System—NUP205—Paget's disease of bone	0.000208	0.000628	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—VCP—Paget's disease of bone	0.000208	0.000627	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000208	0.000625	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—INPP5D—Paget's disease of bone	0.000207	0.000624	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—SQSTM1—Paget's disease of bone	0.000206	0.00062	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000204	0.000613	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—VCP—Paget's disease of bone	0.000203	0.000611	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—INPP5D—Paget's disease of bone	0.000203	0.00061	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—VCP—Paget's disease of bone	0.000201	0.000605	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—INPP5D—Paget's disease of bone	0.000199	0.0006	CbGpPWpGaD
Vandetanib—BLK—Immune System—SQSTM1—Paget's disease of bone	0.000198	0.000596	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000198	0.000596	CbGpPWpGaD
Vandetanib—FGR—Immune System—SQSTM1—Paget's disease of bone	0.000197	0.000594	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000192	0.000579	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—VCP—Paget's disease of bone	0.000192	0.000577	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000186	0.000559	CbGpPWpGaD
Vandetanib—FYN—Disease—VCP—Paget's disease of bone	0.000185	0.000556	CbGpPWpGaD
Vandetanib—YES1—Immune System—PML—Paget's disease of bone	0.000184	0.000555	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—INPP5D—Paget's disease of bone	0.000183	0.000552	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—VCP—Paget's disease of bone	0.000183	0.00055	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—SQSTM1—Paget's disease of bone	0.000182	0.000546	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000179	0.000539	CbGpPWpGaD
Vandetanib—YES1—Immune System—INPP5D—Paget's disease of bone	0.000178	0.000535	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—VCP—Paget's disease of bone	0.000176	0.000531	CbGpPWpGaD
Vandetanib—ABCC1—Disease—VCP—Paget's disease of bone	0.000169	0.00051	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CALCA—Paget's disease of bone	0.000163	0.00049	CbGpPWpGaD
Vandetanib—EGFR—Disease—VCP—Paget's disease of bone	0.00016	0.000481	CbGpPWpGaD
Vandetanib—YES1—Immune System—SQSTM1—Paget's disease of bone	0.000159	0.00048	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NUP205—Paget's disease of bone	0.000159	0.000478	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000159	0.000477	CbGpPWpGaD
Vandetanib—LYN—Immune System—NUP205—Paget's disease of bone	0.000155	0.000468	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NUP205—Paget's disease of bone	0.000155	0.000466	CbGpPWpGaD
Vandetanib—LCK—Disease—VCP—Paget's disease of bone	0.000154	0.000463	CbGpPWpGaD
Vandetanib—FYN—Immune System—NUP205—Paget's disease of bone	0.000153	0.000461	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NUP205—Paget's disease of bone	0.000147	0.000441	CbGpPWpGaD
Vandetanib—FYN—Disease—NUP205—Paget's disease of bone	0.000141	0.000425	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PML—Paget's disease of bone	0.00014	0.000422	CbGpPWpGaD
Vandetanib—LYN—Immune System—PML—Paget's disease of bone	0.000137	0.000414	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PML—Paget's disease of bone	0.000137	0.000412	CbGpPWpGaD
Vandetanib—SRC—Disease—VCP—Paget's disease of bone	0.000136	0.00041	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	0.000135	0.000408	CbGpPWpGaD
Vandetanib—FYN—Immune System—PML—Paget's disease of bone	0.000135	0.000407	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	0.000134	0.000404	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000133	0.000401	CbGpPWpGaD
Vandetanib—LYN—Immune System—INPP5D—Paget's disease of bone	0.000133	0.000399	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NUP205—Paget's disease of bone	0.000132	0.000398	CbGpPWpGaD
Vandetanib—ABL1—Immune System—INPP5D—Paget's disease of bone	0.000132	0.000397	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—VCP—Paget's disease of bone	0.000132	0.000396	CbGpPWpGaD
Vandetanib—FYN—Immune System—INPP5D—Paget's disease of bone	0.000131	0.000393	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NUP205—Paget's disease of bone	0.00013	0.00039	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—VCP—Paget's disease of bone	0.000129	0.00039	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CALCA—Paget's disease of bone	0.000129	0.000389	CbGpPWpGaD
Vandetanib—LCK—Immune System—NUP205—Paget's disease of bone	0.000127	0.000384	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000126	0.000378	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—INPP5D—Paget's disease of bone	0.000124	0.000373	CbGpPWpGaD
Vandetanib—EGFR—Disease—NUP205—Paget's disease of bone	0.000122	0.000367	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000122	0.000367	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	0.000121	0.000365	CbGpPWpGaD
Vandetanib—LYN—Immune System—SQSTM1—Paget's disease of bone	0.000119	0.000358	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000119	0.000357	CbGpPWpGaD
Vandetanib—ABL1—Immune System—SQSTM1—Paget's disease of bone	0.000118	0.000356	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CALCA—Paget's disease of bone	0.000118	0.000356	CbGpPWpGaD
Vandetanib—LCK—Disease—NUP205—Paget's disease of bone	0.000118	0.000354	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000117	0.000353	CbGpPWpGaD
Vandetanib—FYN—Immune System—SQSTM1—Paget's disease of bone	0.000117	0.000352	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PML—Paget's disease of bone	0.000117	0.000352	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CALCA—Paget's disease of bone	0.000115	0.000347	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CALCA—Paget's disease of bone	0.000114	0.000343	CbGpPWpGaD
Vandetanib—SRC—Immune System—NUP205—Paget's disease of bone	0.000113	0.00034	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000113	0.000339	CbGpPWpGaD
Vandetanib—EGFR—Immune System—INPP5D—Paget's disease of bone	0.000113	0.000339	CbGpPWpGaD
Vandetanib—LCK—Immune System—PML—Paget's disease of bone	0.000113	0.000339	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VCP—Paget's disease of bone	0.000112	0.000337	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CALCA—Paget's disease of bone	0.000109	0.000328	CbGpPWpGaD
Vandetanib—LCK—Immune System—INPP5D—Paget's disease of bone	0.000109	0.000327	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NUP205—Paget's disease of bone	0.000108	0.000326	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VCP—Paget's disease of bone	0.000108	0.000324	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CALCA—Paget's disease of bone	0.000107	0.000323	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000107	0.000321	CbGpPWpGaD
Vandetanib—FYN—Disease—CALCA—Paget's disease of bone	0.000105	0.000316	CbGpPWpGaD
Vandetanib—SRC—Disease—NUP205—Paget's disease of bone	0.000104	0.000313	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CALCA—Paget's disease of bone	0.000104	0.000312	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000103	0.00031	CbGpPWpGaD
Vandetanib—EGFR—Immune System—SQSTM1—Paget's disease of bone	0.000101	0.000304	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CALCA—Paget's disease of bone	0.0001	0.000301	CbGpPWpGaD
Vandetanib—SRC—Immune System—PML—Paget's disease of bone	9.97e-05	0.0003	CbGpPWpGaD
Vandetanib—LCK—Immune System—SQSTM1—Paget's disease of bone	9.74e-05	0.000293	CbGpPWpGaD
Vandetanib—SRC—Immune System—INPP5D—Paget's disease of bone	9.62e-05	0.00029	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CALCA—Paget's disease of bone	9.61e-05	0.000289	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NUP205—Paget's disease of bone	9.54e-05	0.000287	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VCP—Paget's disease of bone	9.54e-05	0.000287	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—INPP5D—Paget's disease of bone	9.25e-05	0.000278	CbGpPWpGaD
Vandetanib—EGFR—Disease—CALCA—Paget's disease of bone	9.06e-05	0.000273	CbGpPWpGaD
Vandetanib—LCK—Disease—CALCA—Paget's disease of bone	8.73e-05	0.000263	CbGpPWpGaD
Vandetanib—SRC—Immune System—SQSTM1—Paget's disease of bone	8.62e-05	0.00026	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	8.14e-05	0.000245	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	7.85e-05	0.000236	CbGpPWpGaD
Vandetanib—SRC—Disease—CALCA—Paget's disease of bone	7.73e-05	0.000233	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	7.68e-05	0.000231	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	7.62e-05	0.000229	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SQSTM1—Paget's disease of bone	7.56e-05	0.000228	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	7.46e-05	0.000225	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CALCA—Paget's disease of bone	7.35e-05	0.000221	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SQSTM1—Paget's disease of bone	6.54e-05	0.000197	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CALCA—Paget's disease of bone	6.35e-05	0.000191	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	6.3e-05	0.00019	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	6.12e-05	0.000184	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NUP205—Paget's disease of bone	5.89e-05	0.000177	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SQSTM1—Paget's disease of bone	5.58e-05	0.000168	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CALCA—Paget's disease of bone	5.41e-05	0.000163	CbGpPWpGaD
Vandetanib—ALB—Metabolism—INPP5D—Paget's disease of bone	5.02e-05	0.000151	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	3.18e-05	9.57e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	2.71e-05	8.16e-05	CbGpPWpGaD
